Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.

Endocrine journal - 1 Apr 1998

Hozumi Y, Kawano M, Saito T, Miyata M

Abstract excerpt

We recently reported three cases of severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery. In that report we showed that one of the three patients had apo E3/3 and another had E4/2 phenotype. There are few data about the relationship between apoprotein E phenotype, one of modifiers of lipoprotein metabolism, and tamoxifen induced lipemia. In the present study, we studied apo E...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoproteins E
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholesterol

Share to Hypertriglyceridemia

Share to Lipids

Share to Phenotype

Share to Triglycerides

Source

Identifiers

PMID: 9700480
DOI: 10.1507/endocrj.45.255

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.PMID 9700480Read ↗

Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients.Semantic proximity Read ↗

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?Semantic proximity Read ↗

The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.Semantic proximity Read ↗

Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy.Semantic proximity Read ↗

Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.Semantic proximity Read ↗

Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?Semantic proximity Read ↗

Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.Semantic proximity Read ↗

Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia.Semantic proximity Read ↗

Effects of apolipoprotein E phenotype on serum cholesterol level and cholesterol response to diet therapy in patients with hypercholesterolemia.Semantic proximity Read ↗

The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study.Semantic proximity Read ↗

Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol.Semantic proximity Read ↗

Apolipoprotein E phenotype associations with plasma lipoproteins and bone mass in postmenopausal women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.